TP53 and cancer: Importantly, this finding was further validated in additional tumor cell lines, including HepG2 and HCT116 cells, where circp53 overexpression similarly upregulated the p53 signaling pathway (Supplementary Fig. 2d,e), suggesting a conserved tumor-suppressive mechanism across different cancer types.